Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover study of PDLYT7 in chronic renal failure patients on hemodialysis or hemodiafiltration
jRCT2031250585Active, not recruiting
- Sponsor
- Nipro Corporation
- Start
- Mar 2026
- Countries
- 1
01
Overview
Randomised trial of PDLYT7 in chronic kidney disease (CKD) (2 arms), sponsored by Nipro Corporation. Primary endpoints: Removal rates of urea nitrogen, Removal rates of creatinine and 1 more. Started Mar 2026; status: active, not recruiting.
02
Drugs
PDLYT7
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2031250585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250585.